All Viruses articles – Page 81
-
NewsResearchers infect ‘brain in a dish’ in pursuit of Zika antivirals
A University of Queensland-led project has used a ‘brain in a dish’ to study the effects of the Zika virus, taking research a step closer towards developing drugs to combat the infection.
-
NewsPotential drug takes aim at emerging Chikungunya virus
Researchers are developing what could become the first-ever treatment against the debilitating joint pain that can last months or years after becoming infected with the emerging Chikungunya virus.
-
News New virus discovered in Swiss ticks
Researchers from the Institute of Virology at the University of Zurich (UZH) have detected the Alongshan virus (ALSV) for the first time in ticks in Switzerland.
-
NewsLiquid-coated air filter inspired by carnivorous plant can improve early capture of airborne pathogens
Researchers have designed a new liquid-coated air filter that allows for improved early detection and analysis of airborne bacteria and viruses, including the one that causes COVID-19.
-
NewsResearchers find new viral entryway into host cells for Covid-19
A University of Ottawa-led team has found a new viral entry for SARS-CoV-2, suggesting it may be able to use proteins to infect a wider range of cells.
-
NewsImmune response discovery solves mystery of why colds are more common when it’s cold
Scientists say a newly discovered immune response inside the nose is suppressed by colder temperatures, offering evidence for why colds, flu and COVID-19 are more common in cooler months.
-
NewsWireless device can rapidly spot coronavirus using magnetostrictive composite plates
A collaborative research group has engineered a self-sustaining device that can immediately detect COVID-19 particles in its surroundings.
-
NewsClover’s vaccine candidate reduced household transmission of SARS-CoV-2
A collaboration between Clover Biopharmaceuticals Ltd and the International Vaccine Institute showed that a household contact was 84% less likely to get a SARS-CoV-2 infection when the infected household member had received SCB-2019 (CpG 1018/Alum) compared to placebos.
-
NewsCOVID-19 infection disrupts gut microbes, especially with antibiotics
Acute infection disrupts a healthy balance between good and bad microbes in the gut, especially with antibiotic treatment, researchers have found.
-
NewsResearchers develop tailored Covid neutralizer that can adapt to mutations
A research team at Pohang University of Science and Technology has developed a tailored COVID-19 neutralizer that can adapt to all kinds of mutations in the virus in treating the viral infection.
-
NewsNew Omicron subvariant resistant to all approved therapeutic antibodies
Rrsearchers in Germany have found that the Omicron sub-lineage BQ.1.1, currently on the rise worldwide, is resistant to all the approved antibody therapies used to treat individuals at risk for severe Covid-19 disease.
-
NewsHidden Nsp1 cavity means Covid’s Spike protein is no longer the only target
Researchers have revealed the existence of a hidden ’’pocket’ on the surface of the non-structural protein Nsp1 on the surface of the Covid-19 virus which could offer a potential drug target and alternative to the Spike protein targeted by vaccines.
-
NewsGene-delivering viruses cross into brain in step toward gene therapy for neurological diseases
A family of adeno-associated viruses (AAVs) has been developed that are capable of delivering gene therapies to the brain, a particularly challenging target tissue.
-
NewsHIV infection leaves memory that persists in cells even when virus is gone
A new study explains why people living with HIV may suffer from chronic inflammation, which can put them at an increased risk of developing comorbidities such as cardiovascular disease and neurocognitive dysfunction and how suppression or even eradication of HIV in the body may not resolve it. ...
-
NewsCOVID-19 reanimates latent viruses in cells – particularly in ME patients
Researchers have found that COVID-19 reactivates viruses that had become latent in cells following previous infections, particularly in people with chronic fatigue syndrome, also known as ME/CFS.
-
NewsAMI’s pitch on bacteriophages is winner of My Science Inquiry
Applied Microbiology International’s pitch to explore bacteriophages as an alternative to antimicrobial drugs has been selected by the Commons Science and Technology Committee as the winner of the My Science inquiry.
-
NewsViruses deploy CRISPR system to thwart bacterial defences
Researchers have shown that viruses engineered with a CRISPR-Cas system can thwart bacterial defenses and make selective changes to a targeted bacterium – even when other bacteria are in close proximity.
-
NewsBird flu ‘could hit food availability in run-up to Christmas’
Kingston University Professor of Medical Microbiology Mark Fielder explains why the current strain of avian influenza is so contagious, how best to control the spread and the effect the outbreak is having on farmers, retailers and the UK economy.
-
NewsCoffee compound could offer protection from catching COVID-19
Researchers have shown that a compound found in coffee could help to protect against infection by Covid-19.
-
NewsMonkeypox mutations cause virus to spread rapidly and dodge vaccines
Researchers at the University of Missouri have identified the specific mutations in the monkeypox virus that contribute to its continued infectiousness.